Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
57,000
Employees57,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
57,000
Employees57,000

DGX Key Statistics

Market cap
26.70B
Market cap26.70B
Price-Earnings ratio
24.19
Price-Earnings ratio24.19
Dividend yield
1.36%
Dividend yield1.36%
Average volume
1.07M
Average volume1.07M
High today
$244.30
High today$244.30
Low today
$240.54
Low today$240.54
Open price
$240.78
Open price$240.78
Volume
932.12K
Volume932.12K
52 Week high
$248.84
52 Week high$248.84
52 Week low
$171.18
52 Week low$171.18

Stock Snapshot

With a market cap of 26.7B, Quest Diagnostics(DGX) trades at $241.89. The stock has a price-to-earnings ratio of 24.19 and currently yields dividends of 1.36%.

On 2026-10-23, Quest Diagnostics(DGX) stock moved within a range of $240.54 to $244.30. With shares now at $241.89, the stock is trading +0.6% above its intraday low and -1.0% below the session's peak.

Trading activity shows a volume of 932.12K, compared to an average daily volume of 1.07M.

The stock's 52-week range extends from a low of $171.18 to a high of $248.84.

The stock's 52-week range extends from a low of $171.18 to a high of $248.84.

DGX News

TipRanks 2h
Quest Diagnostics Earnings Call Signals Confident Growth

Quest Diagnostics ((DGX)) has held its Q3 earnings call. Read on for the main highlights of the call. Quest Diagnostics’ latest earnings call struck a notably u...

TechCrunch 12h
Lab testing giant Quest Diagnostics confirms patients’ personal and health data was compromised during breach

Medical lab testing giant Quest Diagnostics has confirmed a cyberattack and data breach affecting an as-yet unspecified amount of sensitive patient information...

Lab testing giant Quest Diagnostics confirms patients’ personal and health data was compromised during breach
Zacks 14h
Why Quest Diagnostics is a Top Momentum Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Z...

Why Quest Diagnostics is a Top Momentum Stock for the Long-Term

Analyst ratings

55%

of 20 ratings
Buy
45%
Hold
55%
Sell
0%

More DGX News

TipRanks 16h
Quest Diagnostics price target raised to $262 from $260 at Baird

Baird analyst Eric Coldwell raised the firm’s price target on Quest Diagnostics (DGX) to $262 from $260 and keeps a Neutral rating on the shares. The firm updat...

Simply Wall St 1d
Quest Diagnostics Q3 Earnings Strength Sharpens Valuation Focus

Quest Diagnostics walked into its Q3 2026 report with a reputation as a steady cash generator in diagnostics and a stock that had already delivered mid‑single d...

Quest Diagnostics Q3 Earnings Strength Sharpens Valuation Focus
Simply Wall St 1d
Quest Diagnostics Just Gave Investors Something To Think About

Quest Diagnostics (DGX) is back in focus after reporting third quarter results that showed higher sales and net income year over year, raising full year guidanc...

Quest Diagnostics Just Gave Investors Something To Think About
The Motley Fool 1d
Quest Diagnostics: 3 Key Takeaways for Long-Term Investors

On its third quarter of 2026 earnings call, held on Oct. 22, 2026, Quest Diagnostics (DGX -1.08%) reported 10% revenue growth and raised its guidance for full-y...

Quest Diagnostics: 3 Key Takeaways for Long-Term Investors
Zacks 1d
DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market

Quest Diagnostics Incorporated (DGX Quick QuoteDGX - Free Report) reported third-quarter 2026 adjusted earnings of $3.00 per share, up 15.4% year over yea...

DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market
Benzinga 1d
Quest Diagnostics Bumps Guidance While Managing Quanum System Breach

Quest Diagnostics Incorporated (NYSE:DGX) on Thursday reported third-quarter adjusted earnings of $3 per share, beating the Wall Street estimate of $2.86. Reve...

Quest Diagnostics Bumps Guidance While Managing Quanum System Breach
TipRanks 1d
Quest Diagnostics discloses breach after ‘unauthorized access’

Quest Diagnostics (DGX) is fractionally down in morning trading after the company said in a regulatory filing that on October 21, it learned of unauthorized acc...

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.